Aronora

Portland, United States Founded: 2009 • Age: 17 yrs
Recombinant monoclonal antibodies and enzymes are developed for thrombotic disorders.

About Aronora

Aronora is a company based in Portland (United States) founded in 2009.. The company has 8 employees as of December 31, 2021. Aronora operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others.

  • Headquarter Portland, United States
  • Employees 8 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $494 K (USD), Grant

    Jun 15, 2024

  • Investors
    HHS

    & 1 more

  • Employee Count
    8

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Aronora

  • Total Funding
  • Total Rounds 18
  • Last Round Grant — $493,999
  • First Round

    (15 Sep 2009)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2024 Amount Grant - Aronora Valuation

investors

HHS
Oct, 2023 Amount Seed - Aronora Valuation

investors

Jun, 2023 Amount Grant - Aronora Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aronora

Aronora has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NYBC Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aronora

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aronora

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aronora Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aronora

Aronora operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Regenerative and gene therapeutics for heart failure are developed.
domain founded_year HQ Location
Developer of autologous cell therapies
domain founded_year HQ Location
Specialized drugs are developed for genetic heart diseases.
domain founded_year HQ Location
Developer of antiviral agents against targets in the treatment of hepatitis
domain founded_year HQ Location
Provider of tools for the analysis of RNA structures
domain founded_year HQ Location
Regenerative medicine for cardiovascular disorders is developed using cell-based platforms.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aronora

Frequently Asked Questions about Aronora

When was Aronora founded?

Aronora was founded in 2009.

Where is Aronora located?

Aronora is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

How many employees does Aronora have?

As of Dec 31, 2021, the latest employee count at Aronora is 8.

What does Aronora do?

Aronora is an early-stage company focussed on developing antithrombotics for blood clots. It is developing recombinant monoclonal antibodies (MAbs) and enzymes as therapeutic agents for acute thrombotic vascular diseases without the detrimental bleeding side effects. Its pipeline has 3 preclinical products AB002, a recombinant antithrombotic and cytoprotective enzyme in pre-clinical development for stand-alone emergency use during acute cardiovascular and cerebral ischemia; AB012, a recombinant protein that selectively inhibits the coagulation factor IX (F9) for moderate bleeding risks and AB022, an MAb that selectively inhibits the coagulation factor XI (F11) for conditions accompanied with thrombosis and bleeding, such as major surgeries, fractures, crushing and head injuries.

Who are the top competitors of Aronora?

Aronora's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.

Who are Aronora's investors?

Aronora has 2 investors. Key investors include HHS, and NYBC Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available